Ceftobiprole Perspective: Current and Potential Future Indications

Ceftobiprole combines an excellent spectrum for community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP) pathogens, with a low/medium MDR risk, and the β-lactams’ safety in frail patients admitted to the hospital in internal medicine wards which may be at high risk of adverse events...

Descripción completa

Detalles Bibliográficos
Autores principales: Lupia, Tommaso, Pallotto, Carlo, Corcione, Silvia, Boglione, Lucio, De Rosa, Francesco Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915564/
https://www.ncbi.nlm.nih.gov/pubmed/33567771
http://dx.doi.org/10.3390/antibiotics10020170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915564/
https://www.ncbi.nlm.nih.gov/pubmed/33567771
http://dx.doi.org/10.3390/antibiotics10020170

Ejemplares similares